Centenial Surg. Sut.
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Centenial Surg. Sut. do?
Centenial Surgical Suture Ltd. specializes in manufacturing a wide range of sterile needled sutures, including absorbable natural and synthetic sutures, non-absorbable sutures, and various medical devices for surgical procedures.
Who are the competitors of Centenial Surg. Sut.?
Centenial Surg. Sut. major competitors are Galaxy Medicare, GKB Ophthalmics, Kretto Syscon, KMS Medisurgi, Amkay Products, Transpact Enterprise, Shree Pacetronix. Market Cap of Centenial Surg. Sut. is ₹29 Crs. While the median market cap of its peers are ₹43 Crs.
Is Centenial Surg. Sut. financially stable compared to its competitors?
Centenial Surg. Sut. seems to be less financially stable compared to its competitors. Altman Z score of Centenial Surg. Sut. is 1.86 and is ranked 8 out of its 8 competitors.
Does Centenial Surg. Sut. pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Centenial Surg. Sut. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Centenial Surg. Sut. allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery
How strong is Centenial Surg. Sut. balance sheet?
Balance sheet of Centenial Surg. Sut. is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of Centenial Surg. Sut. improving?
No, profit is decreasing. The profit of Centenial Surg. Sut. is -₹2.22 Crs for TTM, -₹1.46 Crs for Mar 2025 and ₹1.13 Crs for Mar 2024.
Is the debt of Centenial Surg. Sut. increasing or decreasing?
The net debt of Centenial Surg. Sut. is decreasing. Latest net debt of Centenial Surg. Sut. is ₹10.51 Crs as of Mar-26. This is less than Mar-25 when it was ₹11.84 Crs.
Is Centenial Surg. Sut. stock expensive?
Centenial Surg. Sut. is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Centenial Surg. Sut. is 0, while 3 year average PE is 27.84. Also latest EV/EBITDA of Centenial Surg. Sut. is 7.37 while 3yr average is 6.9.
Has the share price of Centenial Surg. Sut. grown faster than its competition?
Centenial Surg. Sut. has given better returns compared to its competitors. Centenial Surg. Sut. has grown at ~-18.97% over the last 2yrs while peers have grown at a median rate of -19.0%
Is the promoter bullish about Centenial Surg. Sut.?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Centenial Surg. Sut. is 46.89% and last quarter promoter holding is 46.89%.
Are mutual funds buying/selling Centenial Surg. Sut.?
There is Insufficient data to gauge this.